Dromex Brazil
Dromex Brasil is a Campinas-based commercial representation firm founded in 2003 that connects international pharmaceutical and veterinary raw material manufacturers with Brazilian pharmaceutical buyers, generating revenue through transaction commissions via a specialized sales team.
- Company typePrivate
- Founded2003
- HeadquartersCampinas, Brazil
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Dromex Brazil does
Dromex Brasil (legal name: Dromex do Brasil) is a commercial representation company headquartered in Campinas, São Paulo, Brazil, founded in 2003. The firm acts as the exclusive or primary Brazilian commercial representative for approximately 10 international manufacturers of pharmaceutical and veterinary raw materials, including Chirogate, Fernic, Simbiotic, Dangschat, Centrient, Symbiotec, Vital, Welpharm, Wendt Chemie, and Swati. Its single product offering is structured sales representation and technical support connecting these principals with Brazilian pharmaceutical manufacturers, encompassing personalized pre-sale engagement, technical documentation, regulatory/compliance support for raw material qualification with ANVISA-related dossiers, and post-sale service. The go-to-market is sales-led: a specialized in-house sales team engages enterprise pharma buyers directly, with industry trade shows (notably FCE Pharma in São Paulo and CPHI Worldwide in Europe) functioning as the principal marketing and sourcing channel for both principals and customers. Dromex Brasil does not produce, warehouse, or take title to the raw materials it represents; revenue is earned through commissions or transaction margins on sales it facilitates between its principals and Brazilian buyers. It serves roughly 17 named enterprise customers across human and veterinary pharmaceuticals, including EMS, Eurofarma, Libbs, Teuto, Prati, Cimed, Ourofino, Blau, Syntec, Momenta, Noxon, UCBV, União Química, Calbos, ACGE, Bimeda, and Drogavet. The firm operates a single office in Campinas with 11–50 employees, has no subsidiaries, no disclosed institutional investment, and no disclosed capital structure; it is privately held with no public listing.
Dromex Brazil firmographics
Firmographics- Name
- Dromex Brazil
- Legal name
- Dromex do Brasil
- Website
- https://dromex.com.br
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Dromex Brasil is a Campinas-based commercial representation firm founded in 2003 that connects international pharmaceutical and veterinary raw material manufacturers with Brazilian pharmaceutical buyers, generating revenue through transaction commissions via a specialized sales team.
- Ownership category
- akta.pro rank
Dromex Brazil industry classification
Industry- Product category
- Pharmaceutical Raw Materials Commercial Representation
- SIC
- Medicinal Chemicals & Botanical Products (2833), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Veterinary Medical/Surgical Supply Wholesalers (HLAMAIAB)
Keywords
Where Dromex Brazil is headquartered
LocationHeadquarters
- HQ city
- Campinas
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
Dromex Brazil business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations
Revenue model
- Commercial Representation Services: Dromex Brasil generates revenue through commercial representation of international raw material manufacturers for the pharmaceutical and veterinary industries in Brazil. The company acts as an intermediary, connecting manufacturers with Brazilian pharmaceutical companies, earning commissions or margins on transactions facilitated through their sales team.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Dromex Brazil product offering
Product offeringCore offering
Dromex Brasil provides commercial representation services in Brazil for international manufacturers of raw materials used in the pharmaceutical and veterinary industries. The company connects globally recognized raw material manufacturers with Brazilian pharmaceutical and veterinary drug producers, offering a specialized sales team that provides personalized service and technical support from initial contact through post-sale assistance.
Product overview
Dromex Brasil operates as a commercial representation company that connects pharmaceutical and veterinary raw material manufacturers with Brazilian industry clients. The company offers a single unified service focused on commercial representation, providing access to an extensive portfolio of internationally recognized raw material suppliers. The service includes personalized sales support, technical assistance, and comprehensive customer service from initial contact through post-sale support.
Differentiator
Problem solved
Functional benefit
Products and services
- Commercial Representation Services for Pharmaceutical and Veterinary Raw Materials Standalone B2B service in which Dromex Brasil acts as the local commercial representative (representada) in Brazil for a portfolio of international pharmaceutical and veterinary raw material manufacturers. The service includes sourcing, sales engagement, technical support, and post-sale assistance provided to Brazilian pharmaceutical and veterinary drug producers that procure excipients and APIs through Dromex's specialized sales team.
Companies that use Dromex Brazil
Customer profileNamed customers17 records
Segments1 record
Ideal customer profiles2 records
Dromex Brazil technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Dromex Brazil partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core.
- ChirogatecoreInternational manufacturer of pharmaceutical raw materials represented by Dromex Brasil in the Brazilian market. Part of the portfolio of represented manufacturers serving the pharmaceutical industry.
- FerniccoreInternational manufacturer of pharmaceutical raw materials represented by Dromex Brasil in the Brazilian market. Part of the portfolio of represented manufacturers serving the pharmaceutical industry.
- SimbioticcoreInternational manufacturer of pharmaceutical raw materials represented by Dromex Brasil in the Brazilian market. Part of the portfolio of represented manufacturers serving the pharmaceutical industry.
- DangschatcoreInternational manufacturer of pharmaceutical raw materials represented by Dromex Brasil in the Brazilian market. Part of the portfolio of represented manufacturers serving the pharmaceutical industry.
- CentrientcoreInternational manufacturer of pharmaceutical raw materials represented by Dromex Brasil in the Brazilian market. Part of the portfolio of represented manufacturers serving the pharmaceutical industry.
- SymbioteccoreInternational manufacturer of pharmaceutical raw materials represented by Dromex Brasil in the Brazilian market. Part of the portfolio of represented manufacturers serving the pharmaceutical industry.
- VitalcoreInternational manufacturer of pharmaceutical raw materials represented by Dromex Brasil in the Brazilian market. Part of the portfolio of represented manufacturers serving the pharmaceutical industry.
- WelpharmcoreInternational manufacturer of pharmaceutical raw materials represented by Dromex Brasil in the Brazilian market. Part of the portfolio of represented manufacturers serving the pharmaceutical industry.
- Wendt ChemiecoreInternational manufacturer of pharmaceutical raw materials represented by Dromex Brasil in the Brazilian market. Part of the portfolio of represented manufacturers serving the pharmaceutical industry.
- SwaticoreInternational manufacturer of pharmaceutical raw materials represented by Dromex Brasil in the Brazilian market. Part of the portfolio of represented manufacturers serving the pharmaceutical industry.
Scale indicators1 record
Recent moves5 records
Expansion highlights4 records
Dromex Brazil competitors and assessment
Company assessmentBroad incumbents
- IMCD: Global specialty chemicals and ingredients distributor with significant presence in Brazil serving pharmaceutical, food, and personal care customers. Comparable in operating model (multi-principal distribution with technical sales), though far larger and more diversified across categories and geographies.
- Azelis: Global specialty ingredients distributor with life sciences and pharma coverage across Latin America. Operates the same multi-principal distribution model serving pharmaceutical manufacturers with technical sales support.
- Univar Solutions: Global specialty ingredients and chemicals distributor with a pharmaceutical and life sciences segment, including operations in Brazil. Comparable in representing multiple international ingredient manufacturers and selling into Brazilian pharmaceutical customers.
- Brenntag: World's largest chemical and ingredients distributor with dedicated life sciences operations in Brazil distributing APIs, excipients, and specialty ingredients. Closely comparable business model (multi-principal distribution to pharma manufacturers) but at vastly greater scale.
- Barentz: Global specialty ingredients distributor serving pharmaceutical, nutraceutical, and personal care manufacturers with a presence in Latin America. Directly comparable multi-principal distribution model targeting the same pharmaceutical customer base.
Direct peers
- Fagron: Pharmaceutical compounding ingredients supplier and distributor with established operations in Brazil, serving both human and veterinary pharma customers. Highly comparable as a specialty pharma ingredients distributor with technical and commercial representation.
- Selectchemie: Pharmaceutical and nutraceutical ingredients distributor representing international manufacturers across multiple geographies including Latin America. Comparable in scale and operating model to Dromex, distributing APIs and excipients to pharmaceutical customers.
- Prinova: Specialty ingredients distributor focused on nutritional, health, and pharmaceutical ingredients globally, including Latin America. Comparable in distributing APIs, excipients, and nutraceutical ingredients to pharmaceutical manufacturers.
- Galena Química e Farmacêutica: Brazilian pharmaceutical ingredients distributor and commercial representative serving domestic pharma customers. Directly comparable business model (multi-principal distribution, Brazil-only, B2B raw materials) and similar customer profile.
- Sinteuropa: Brazilian specialty pharmaceutical and nutraceutical ingredients distributor, also acting as commercial representative for international manufacturers. The closest direct peer in geography, business model, and customer profile.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key highlights6 records
Customer concentration
Dromex Brazil social profiles
Digital presenceDromex Brazil financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dromex Brazil leadership team
Management profileNumber of profiles
Dromex Brazil funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dromex Brazil M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dromex Brazil
What does Dromex Brazil do?
Dromex Brasil provides commercial representation services in Brazil for international manufacturers of raw materials used in the pharmaceutical and veterinary industries. The company connects globally recognized raw material manufacturers with Brazilian pharmaceutical and veterinary drug producers, offering a specialized sales team that provides personalized service and technical support from initial contact through post-sale assistance.
Is Dromex Brazil a public or private company?
Dromex Brazil is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Dromex Brazil founded?
Dromex Brazil was founded in 2003. It employs 11 to 50 people.
Where is Dromex Brazil based?
Dromex Brazil is headquartered in Campinas, Brazil, in the Latin America region.
How does Dromex Brazil make money?
One revenue line is on record: commercial Representation Services.
Who are Dromex Brazil's main competitors?
Broad incumbents on record are IMCD, Azelis, Univar Solutions, Brenntag and Barentz. Direct peers are Fagron, Selectchemie, Prinova, Galena Química e Farmacêutica and Sinteuropa.
Does Dromex Brazil have an API?
No public API is recorded for Dromex Brazil.
What industry is Dromex Brazil in?
Dromex Brazil's product category is Pharmaceutical Raw Materials Commercial Representation. Its primary akta.pro industry code is HLAMAIAB, Veterinary Medical/Surgical Supply Wholesalers. Its SIC code is 2833.